Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned under...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motivation and perceived learning in serious games: Reflexive thematic analysis of educational escape room experiences.

Medical teacher·2026
Same author

Single-dose intraoperative methadone QTc effects. Comment on Br J Anaesth 2026.

British journal of anaesthesia·2026
Same author

A Longitudinal Assessment for Continuing Certification of Anesthesiologists: Utilization, Performance, and Perception of MOCA Minute.

Anesthesiology·2026
Same author

Trajectories of Pain Scores and Analgesic Administration Following Cardiac Surgery.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Prognostic Value of 60-Day Temporary Peripheral Nerve Stimulation in Predicting Analgesic Outcomes After Permanent Peripheral Nerve Stimulator Implantation: A Multicenter Analysis.

Neuromodulation : journal of the International Neuromodulation Society·2025
Same author

Anesthesia and Babies' Brains: Lessons from the Lounge.

Anesthesiology·2025

Related Experiment Video

Updated: Jun 30, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Bronchospasm after intravenous lidocaine.

Bobby R Burches1, David O Warner

  • 1Department of Anesthesiology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA.

Anesthesia and Analgesia
|September 23, 2008
PubMed
Summary

Intravenous lidocaine can cause temporary airway narrowing, specifically bronchospasm, in children with asthma. This adverse event, though transient, highlights a potential risk during medical procedures for asthmatic patients.

More Related Videos

Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow
05:43

Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow

Published on: January 13, 2017

Related Experiment Videos

Last Updated: Jun 30, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow
05:43

Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow

Published on: January 13, 2017

Area of Science:

  • Anesthesiology
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Airway management during anesthesia is critical in pediatric patients.
  • Asthma is a common chronic respiratory disease in children, characterized by airway hyperresponsiveness.
  • Intravenous lidocaine is frequently used for its anesthetic and antiarrhythmic properties, including facilitating endotracheal intubation.

Observation:

  • A 17-month-old female with mild intermittent asthma experienced acute bronchospasm immediately following intravenous lidocaine administration (1.5 mg/kg) for endotracheal intubation.
  • The patient exhibited diffuse bilateral expiratory wheezes and a significant increase in peak inspiratory pressure.
  • The bronchospastic episode resolved spontaneously within approximately 5 minutes, allowing for an otherwise uneventful anesthetic course.

Findings:

  • The observed transient bronchospasm in an asthmatic child following IV lidocaine administration aligns with emerging clinical evidence.
  • Intravenous lidocaine may induce airway narrowing in patients with asthma, a condition associated with heightened airway reactivity.
  • This case underscores the potential for IV lidocaine to precipitate bronchospasm in susceptible pediatric patients.

Implications:

  • Clinicians administering intravenous lidocaine to pediatric asthmatic patients should be aware of the potential for bronchospasm.
  • Careful patient selection and monitoring are recommended when using IV lidocaine in asthmatic individuals.
  • Further research is warranted to elucidate the mechanisms and prevalence of IV lidocaine-induced airway narrowing in asthmatics.